术后非小细胞肺癌的自适应疗法:以动态最小残留疾病调整为指导的策略
Li-Jin Xie1, Li-Li Fu1, Shu-Cen Liu2
1Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, 368 Yehai Road, Haikou, 570311, China.
Translational oncology
|January 7, 2026
概括
使用先进的液体活检检测最小残留病 (MRD) 检测提供了一种管理非小细胞肺癌 (NSCLC) 的新方法. 这种方法可以进行精确指导的治疗调整,并提高预后准确度,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 分子诊断学 分子诊断学
- 癌症基因组学 癌症基因组学
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因,目前的治疗方法因晚期诊断和转移而受到限制.
- 现有的TNM分期系统不足以捕捉瘤异质性和分子变化,影响复发预测和预后.
- 检测最小残留疾病 (MRD) 是克服这些局限性的有希望的途径.
研究的目的:
- 审查在NSCLC检测MRD的技术进步.
- 突出MRD在指导适应性NSCLC治疗中的临床实用性,包括治疗升级/降级和药物假期.
- 引入四维TNMB分期系统,以提高预后分层.
主要方法:
- 对MRD检测技术的系统审查,重点是超敏感液体活检.
- 分析MRD在NSCLC适应性治疗策略中的临床意义.
- 讨论拟议的四维TNMB分期系统,包括分子监测.
主要成果:
- 超敏感液体活检技术为持续的,基于精度的肺癌管理提供了一种变革性的方法.
- 检测MRD有助于做出适应性治疗决策,包括治疗调整和精确指导药物假期.
- 四维TNMB分期系统旨在通过整合持续的分子监测来提高预后准确性.
结论:
- 以MRD为指导的策略,利用先进的液体活检和多组学,承诺转向精确指导,闭环管理NSCLC的范式转变.
- 克服标准化和敏感性等挑战对于临床实施至关重要.
- 这种方法将为全面的,分子驱动的NSCLC管理奠定基础.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K